Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12608)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 14, 2020 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zheng NN, Zhou M, Sun F, Huai MX, Zhang Y, Qu CY, Shen F, Xu LM. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression. World J Gastroenterol 2020; 26(26): 3737-3749 [PMID: 32774054 DOI: 10.3748/wjg.v26.i26.3737] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i26/3737.htm |
| Number | Citing Articles |
| 1 |
Yuanling Zhang, Junhao Chen, Hang Liu, Rui Mi, Rui Huang, Xian Li, Fei Fan, Xueqing Xie, Jie Ding. The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1099892
|
| 2 |
Zhanbo Sun, Lixian Liu, Jun Chen. Targeting non-histone methylation in gastrointestinal cancers: From biology to clinic. European Journal of Medicinal Chemistry 2024; 278: 116802 doi: 10.1016/j.ejmech.2024.116802
|
| 3 |
Stephanie Hufnagel, Haiyue Xu, Michael F. Colemam, Solange A. Valdes, Kristyn A. Liu, Stephen D. Hursting, Zhengrong Cui. 4-(N)-Docosahexaenoyl 2’, 2’-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent. Cancer Chemotherapy and Pharmacology 2022; 89(1): 59 doi: 10.1007/s00280-021-04367-2
|
| 4 |
Jia-Dan Zhou, Hong-Zhang Shen. Advances in pancreatic cancer epigenetics: From the mechanism to the clinic. World Journal of Gastrointestinal Oncology 2025; 17(7): 106238 doi: 10.4251/wjgo.v17.i7.106238
|
| 5 |
Ming Li Jin, Kwang Won Jeong. Histone modifications in drug-resistant cancers: From a cancer stem cell and immune evasion perspective. Experimental & Molecular Medicine 2023; 55(7): 1333 doi: 10.1038/s12276-023-01014-z
|
| 6 |
Bin Wang, Dong Ding, Xiaoan Zhang, Junxi Zhang, Huanhuan Zhang, Xinxin Liu, Hui Chang, Zhan Gao, Zengli Yu. The Role of Protein Arginine Methyltransferases in Pathogenesis and Treatment of Digestive System Carcinoma. Molecular Cancer Therapeutics 2023; 22(8): 926 doi: 10.1158/1535-7163.MCT-22-0746
|
| 7 |
Jia Yan, Ke xin Li, Lei Yu, Heng Yuan, Zhi Zhao, Jing Lin, Chang Shan Wang. PRMT1 Integrates Immune Microenvironment and Fatty Acid Metabolism Response in Progression of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 15 doi: 10.2147/JHC.S443130
|
| 8 |
Jorg Tost, Secil Ak-Aksoy, Daniele Campa, Chiara Corradi, Riccardo Farinella, Alejandro Ibáñez-Costa, Juan Dubrot, Julie Earl, Emma Barreto Melian, Agapi Kataki, Georgina Kolnikova, Gjorgji Madjarov, Marija Chaushevska, Jan Strnadel, Miljana Tanić, Miroslav Tomas, Peter Dubovan, Maria Urbanova, Verona Buocikova, Bozena Smolkova. Leveraging epigenetic alterations in pancreatic ductal adenocarcinoma for clinical applications. Seminars in Cancer Biology 2025; 109: 101 doi: 10.1016/j.semcancer.2025.01.003
|
| 9 |
Remya P. G. Ramesh, Hadida Yasmin, Pretty Ponnachan, Basel Al-Ramadi, Uday Kishore, Ann Mary Joseph. Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1573522
|
| 10 |
Tianli Zhang, Mengmeng Liu, Qing Liu, Gary Guishan Xiao. Wogonin increases gemcitabine sensitivity in pancreatic cancer by inhibiting Akt pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1068855
|
| 11 |
Weijing Dai, Jianguo Zhang, Siqi Li, Fajian He, Qiao Liu, Jun Gong, Zetian Yang, Yan Gong, Fang Tang, Zhihao Wang, Conghua Xie. Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.865964
|
| 12 |
Sara A. Murphy, Norman John Mapes, Devika Dua, Balveen Kaur. Histone modifiers at the crossroads of oncolytic and oncogenic viruses. Molecular Therapy 2022; 30(6): 2153 doi: 10.1016/j.ymthe.2022.02.006
|
| 13 |
Daphne de Korte, Menno Hoekstra. Protein Arginine Methyltransferase 1: A Multi-Purpose Player in the Development of Cancer and Metabolic Disease. Biomolecules 2025; 15(2): 185 doi: 10.3390/biom15020185
|
| 14 |
Ketao Jin, Xiufeng Chu, Jun Qian. Arginine and colorectal cancer: Exploring arginine-related therapeutic strategies and novel insights into cancer immunotherapies. International Immunopharmacology 2025; 148: 114146 doi: 10.1016/j.intimp.2025.114146
|
| 15 |
Ying Xu, Qing Zhu. Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(5): 4820 doi: 10.3390/ijms24054820
|
| 16 |
Kazumichi Kawakubo, Carlos Fernandez-del Castillo, Andrew Scott Liss. Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy. Journal of Gastroenterology 2022; 57(11): 819 doi: 10.1007/s00535-022-01915-2
|
| 17 |
Yuancheng Wei, Xiaodan Lyu, Jia Wang, Liufeng Zhang, Chenxi Xu, Shengtao Yuan, Li Sun. Targeting protein arginine methyltransferases in breast cancer: Promising strategies. European Journal of Pharmacology 2025; 992: 177350 doi: 10.1016/j.ejphar.2025.177350
|
| 18 |
Wenhao Luo, Lianfang Zheng, Taiping Zhang. Do novel treatment strategies enhance T cell-mediated Immunity: Opportunities and challenges in pancreatic cancer immunotherapy. International Immunopharmacology 2021; 90: 107199 doi: 10.1016/j.intimp.2020.107199
|
| 19 |
Kritisha Bhandari, Wei-Qun Ding. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy. International Journal of Molecular Sciences 2024; 25(7): 3958 doi: 10.3390/ijms25073958
|
| 20 |
Hong-Bo Li, Zi-Han Yang, Qing-Qu Guo. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review. Cell Communication and Signaling 2021; 19(1) doi: 10.1186/s12964-021-00789-w
|
| 21 |
Samyuktha Suresh, Solène Huard, Amélie Brisson, Fariba Némati, Rayan Dakroub, Coralie Poulard, Mengliang Ye, Elise Martel, Cécile Reyes, David C. Silvestre, Didier Meseure, André Nicolas, David Gentien, Hussein Fayyad-Kazan, Muriel Le Romancer, Didier Decaudin, Sergio Roman-Roman, Thierry Dubois. PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer. Cancers 2022; 14(2): 306 doi: 10.3390/cancers14020306
|
| 22 |
Yaolin Xu, Lijie He, Qiang Fu, Junzhe Hu. Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.759015
|
| 23 |
Jian Xu, Stéphane Richard. Cellular pathways influenced by protein arginine methylation: Implications for cancer. Molecular Cell 2021; 81(21): 4357 doi: 10.1016/j.molcel.2021.09.011
|
| 24 |
Jin Zou, Wei Shen, Yu Zhang, Shibo Ying. Post-Translational Modifications in Cellular Functions and Diseases. 2021; doi: 10.5772/intechopen.96197
|
| 25 |
Yutong Zhao, Cheng Qin, Chen Lin, Zeru Li, Bangbo Zhao, Tianyu Li, Xiangyu Zhang, Weibin Wang. Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(6): 189183 doi: 10.1016/j.bbcan.2024.189183
|
| 26 |
Ao-Yu Li, Hui-Ni Xiao, Zi-Yue Zhao, Cheng Xiang, Zhuo-yuan Chen, Ping-xiao Wang, Yu Xia, Bin Yu, Hui Li, Tao Xiao. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation. Journal of Cancer Research and Clinical Oncology 2023; 149(11): 9105 doi: 10.1007/s00432-023-04849-1
|
| 27 |
Román Martí-Díaz, Luis Sánchez-del-Campo, María F. Montenegro, Trinidad Hernández-Caselles, Antonio Piñero-Madrona, Juan Cabezas-Herrera, José Neptuno Rodríguez-López. Ex vivo engineering of phagocytic signals in breast cancer cells for a whole tumor cell-based vaccine. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-14432-1
|
| 28 |
Zhe-Nan Ling, Yi-Fan Jiang, Jun-Nan Ru, Jia-Hua Lu, Bo Ding, Jian Wu. Amino acid metabolism in health and disease. Signal Transduction and Targeted Therapy 2023; 8(1) doi: 10.1038/s41392-023-01569-3
|
| 29 |
Jean-Paul Bryant, John Heiss, Yeshavanth Kumar Banasavadi-Siddegowda. Arginine Methylation in Brain Tumors: Tumor Biology and Therapeutic Strategies. Cells 2021; 10(1): 124 doi: 10.3390/cells10010124
|
| 30 |
Nivine Srour, Sarah Khan, Stephane Richard. The Influence of Arginine Methylation in Immunity and Inflammation. Journal of Inflammation Research 2022; : 2939 doi: 10.2147/JIR.S364190
|
| 31 |
Jemma Arakelyan, Daniil A. Rusanov, Meng Rui Chang, Aleksandra V. Asaturova, Galina S. Kireeva, Mana Alshehri, Wee Han Ang, Maria V. Babak. Targeting emerging cancer hallmarks by transition metal complexes: Epigenetic reprogramming and epitherapies. Part II. Coordination Chemistry Reviews 2023; 475: 214899 doi: 10.1016/j.ccr.2022.214899
|